MARKET

SENS

SENS

Senseonics
AMEX
1.089
-0.072
-6.16%
Opening 15:48 11/28 EST
OPEN
1.130
PREV CLOSE
1.160
HIGH
1.155
LOW
1.080
VOLUME
1.91M
TURNOVER
1.18M
52 WEEK HIGH
3.890
52 WEEK LOW
0.7701
MARKET CAP
520.58M
P/E (TTM)
2.882
1D
5D
1M
3M
1Y
5Y
Senseonics Holdings shares dip on tightening FY2022 revenue outlook
Seekingalpha · 11/09 15:31
Senseonics Holdings, Inc. Common Stock Q3 EPS $(0.13) Down From $0.08 YoY, Sales $4.62M Beat $4.31M Estimate
Benzinga · 11/08 21:27
Senseonics GAAP EPS of -$0.13 misses by $0.09, revenue of $4.62M beats by $0.31M
Seekingalpha · 11/08 21:10
Senseonics Holdings, Inc. Reports Third Quarter 2022 Financial Results
GERMANTOWN, Md., November 08, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, t...
Business Wire · 11/08 21:05
-- Earnings Flash (SENS) SENSEONICS HOLDINGS Reports Q3 Revenue $4.6M, vs. Street Est of $4.31M
-- Earnings Flash (SENS) SENSEONICS HOLDINGS Reports Q3 Revenue $4.6M, vs. Street Est of $4.31M
MT Newswires · 11/08 16:27
BRIEF-Senseonics And Ascensia Announce Collaboration With Nurse Practitioner Group
Reuters · 11/03 12:50
Senseonics And Ascensia Announce A Collaboration With The Nurse Practitioner Group Designed To Expand Patient Access By Providing In-office And At-home Insertion Options For Eversense E3 Continuous Glucose Monitoring System
Benzinga · 11/03 12:17
Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 8, 2022, at 4:30 p.m. Eastern Time
GERMANTOWN, Md., October 25, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, tod...
Business Wire · 10/25 20:05
More
About SENS
Senseonics Holdings, Inc. is a medical technology company. The Company is focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community. Its Eversense, Eversense XL and Eversense E3 continuous glucose monitoring (CGM) systems are designed to continually to measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a mobile application for real-time diabetes monitoring and management for a period of up to six months. It is also developing its Freedom product variation to allow for a two-in-one glucose monitoring system combining the functionality of CGM and Flash Glucose Monitoring (FGM), in an implantable sensor, which can be utilized with a smart transmitter to get continuous glucose readings and alerts, or be utilized through a swipe over the sensor with a smart phone to get on-demand glucose reading without a smart transmitter.

Webull offers kinds of Senseonics Holdings Inc stock information, including AMEX:SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SENS stock methods without spending real money on the virtual paper trading platform.